Holista Colltech Limited (ASX:HCT)

Australia · Delayed Price · Currency is AUD

0.0490

+0.0010 (2.08%)

Aug 26, 2026, 1:32 PM AEST

-44.32% (1Y)

Market Cap	17.66M -47.3%
Revenue (ttm)	5.79M +3.1%
Net Income	-948.92K
EPS	-0.00
Shares Out	367.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	201
Open	0.0490
Previous Close	0.0480
Day's Range	0.0490 - 0.0490
52-Week Range	0.0460 - 0.1100
Beta	1.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it offers GI LiTE, a premix glycemic ... [Read more]

Industry Packaged Foods

Sector Consumer Staples

CEO Leong Loong

Employees 58

Stock Exchange Australian Securities Exchange

Ticker Symbol HCT

Full Company Profile

Financial Performance

In 2025, Holista Colltech's revenue was 5.79 million, an increase of 3.08% compared to the previous year's 5.61 million. Losses were -948,921, 1026.8% more than in 2024.

Financial Statements